The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction

NCT06732648 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

725

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Cerebral Edema Following Large Hemispheric Infarction

Interventions

DRUG: HRS8179 injection
DRUG: HRS8179 blank preparation.

Sponsor

Beijing Suncadia Pharmaceuticals Co., Ltd